Editor's note: This story was updated after publication to include an updated quote from Dr. Debra Patt, and to clarify the collaboration between St. David’s South Austin Medical Center and Texas Oncology.
Access to blood cancer treatment and cellular therapy is expanding for residents in the Greater Austin area.
The overview
The Sarah Cannon Transplant and Cellular Therapy Program at St. David’s South Austin Medical Center announced a collaboration with Texas Oncology in April. The relationship will allow St. David’s South Austin Medical Center physicians to treat blood cancer and cellular therapy patients within Texas Oncology offices in Round Rock.
What they're saying
“I am incredibly proud of the collaboration between St. David’s HealthCare and Texas Oncology to expand access to cutting-edge therapies for blood cancer patients in Central Texas,” said Dr. Debra Patt, executive vice president of policy and strategy and managing medical director for the Central and South Texas and Gulf Coast regions of Texas Oncology, in a news release. “This joint effort reflects the strength of a value-based approach to care, one that allows us to work more seamlessly together, accelerate innovation and ensure patients have access to the most advanced treatments close to home.”
“For patients who need transplant or cellular therapy, timing, coordination and access to specialized care determine outcomes,” said Aravind Ramakrishnan, medical director of the Sarah Cannon Transplant and Cellular Therapy Program at St. David’s South Austin Medical Center, in the release. “Our shared focus is enhancing the patient experience and ensuring every individual receives seamless, high-quality care throughout their treatment journey.”
